Less Ads, More Data, More Tools Register for FREE

Pin to quick picksScience Sprt Regulatory News (SIS)

  • This share is currently suspended. It was suspended at a price of 33.50
  • There is currently no data for SIS

AGM Statement

25 Jun 2020 07:00

RNS Number : 9954Q
Science in Sport PLC
25 June 2020
 

 

 

25 June 2020

 

 

 

SCIENCE IN SPORT PLC

("Company" or "Group")

AGM Statement

 

Science in Sport plc (AIM: SIS), the premium performance nutrition company serving elite athletes, sports enthusiasts and the gym lifestyle community, announces the following statement from its Chairman, John Clarke, ahead of the Company's Annual General Meeting ("AGM") to be held this morning.

 

"As previously announced, the Company had conducted a number of scenario analyses which modelled the impact of COVID-19 on revenues for the current financial year and into 2021. Trading is currently in line with the base scenario developed as part of our contingency planning. As expected, retail sales in all markets remain adversely affected compared with normal levels. However, we are making very strong progress with our e-commerce business, with our own PhD and SiS platforms performing well, and our Amazon business outperforming. Pricing improvements and supply chain synergies are delivering an improved gross margin. This, together with planned COVID-19 cost cutting measures now implemented, is protecting our strong cash position.

 

"The Company's financial position remains robust given performance in line with our base scenario. The proceeds from the ÂŁ4.5 million placing in April 2020 means the Company has substantial headroom and can exit the current trading environment well placed to deliver on its long-term growth strategy. As a further contingency we put in place an ÂŁ8.0 million invoice financing debt facility, which remains unused.

 

"Despite the continued high degree of uncertainty from the COVID-19 pandemic and associated economic impact, our strategy remains unchanged, focusing on science-led innovation, building brand equity, taking our share of e-commerce business and developing global markets. We are confident that we are well prepared to deliver on this strategy and will provide further details on progress in our half year results announcement on 16 September 2020.

 

"On behalf of the Board, I would like to thank all employees of the Group for their commitment to the Company in the face of the challenges presented by the COVID-19 pandemic. As a result of their dedication and professionalism, we have continued to serve customers throughout the first half of the year without interruption."

 

For further information:

 

Science in Sport plc

Stephen Moon, Chief Executive Officer

James Simpson, Chief Financial Officer

+44 (0) 20 7400 3700

LiberumNominated adviser and broker

Bidhi BhomaJames GreenwoodWill Hall

+44 (0) 20 3100 2000

 

Notes to Editors

 

About Science in Sport plc

 

Science in Sport plc is a leading sports nutrition business that develops, manufactures and markets innovative nutrition products for professional athletes, sports and fitness enthusiasts and the gym lifestyle community. The Company has two highly regarded brands: PhD Nutrition, a premium protein brand targeting gym lifestyle and sports enthusiasts, and SiS, a leading brand among elite athletes and professional sports teams.

The two brands are sold internationally through multiple retail channels, both traditional and online, including major supermarkets and high street chains, specialist sports retailers and e-commerce sites including Amazon and the brands' own websites. They enable the Company to address the full breadth of the performance nutrition market currently estimated at approximately £10 billion worldwide.

PhD is one of the UK's leading protein brands with a reputation for high quality and product innovation. The brand has grown rapidly, based on its core protein powders, since launch in 2005. The range now comprises powders, bars, flapjacks, drinks and other products including the high protein, low sugar range, PhD Smart. PhD brand ambassadors include endurance athlete Ross Edgley, WBA international champion Jordan Gill, Team GB Olympic sprinter Asha Philip and leading fitness influencer Obi Vincent. The PhD brand is an official partner to the Tough Mudder Challenge and Race Series.

SiS, founded in 1992, has a core range comprising gels, powders and bars focused on energy, hydration and endurance. SiS is the official sports nutrition supplier to many professional teams and organisations including Team INEOS Cycling, Team Ineos UK (America's Cup Team), British Cycling, Cycling Australia, USA Cycling and USA Triathlon. SiS supplies more than 100 professional football clubs in the UK, Europe and USA, and is an official partner to the Rock 'n' Roll Marathon Series. SiS brand ambassadors include Olympians Sir Chris Hoy MBE, Mark Cavendish MBE and Adam Peaty MBE.

Science in Sport is headquartered in London. Its shares joined the AIM market of the London Stock Exchange in August 2013 and trade under the ticker symbol SIS.

For further information, please visit www.scienceinsport.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
AGMSELFMLESSEDM
Date   Source Headline
15th Jan 20212:00 pmRNSPrice Monitoring Extension
14th Jan 20217:00 amRNSPre-Close Trading Update
4th Jan 20217:00 amRNSDates for Investor Presentation and Trading Update
4th Dec 20208:52 amRNSNotification of Major Holdings
3rd Dec 202012:16 pmRNSNotification of Major Holdings
3rd Dec 20209:05 amRNSSecond Price Monitoring Extn
3rd Dec 20209:00 amRNSPrice Monitoring Extension
2nd Dec 20207:00 amRNSTrading Update
19th Nov 20207:00 amRNSIntroduction of Recyclable Packaging Range
17th Nov 202011:52 amRNSNotification of Major Holdings
3rd Nov 20204:17 pmRNSHolding(s) in Company
5th Oct 20207:00 amRNSPDMR Share Purchases
1st Oct 20207:00 amRNSGrant of Options
21st Sep 20202:05 pmRNSSecond Price Monitoring Extn
21st Sep 20202:00 pmRNSPrice Monitoring Extension
21st Sep 202011:06 amRNSSecond Price Monitoring Extn
21st Sep 202011:00 amRNSPrice Monitoring Extension
21st Sep 20209:05 amRNSSecond Price Monitoring Extn
21st Sep 20209:00 amRNSPrice Monitoring Extension
16th Sep 20207:00 amRNSInterim Results
10th Sep 20204:39 pmRNSHolding(s) in Company
7th Sep 20207:00 amRNSInvestor Presentation
9th Jul 20207:00 amRNSHalf Year Trading Update
30th Jun 20203:32 pmRNSNotification of Major Holdings
25th Jun 20205:03 pmRNSResult of AGM
25th Jun 20207:00 amRNSAGM Statement
2nd Jun 20207:00 amRNSNotice of AGM
21st May 20207:00 amRNSNew Debt Financing Facility
28th Apr 20206:02 pmRNSNotification of Major Holdings
28th Apr 20204:11 pmRNSNotification of Major Holdings
28th Apr 20201:21 pmRNSNotification of Major Holdings
24th Apr 20204:22 pmRNSNotification of Major Holdings
24th Apr 20202:41 pmRNSNotification of Major Holdings
23rd Apr 20207:50 amRNSResult of Placing and Director/PDMR Dealings
22nd Apr 20204:51 pmRNSProposed Placing of New Ordinary Shares
17th Apr 202012:05 pmRNSAnnual Report & Accounts
18th Mar 20207:00 amRNSFinal Results
11th Mar 20205:34 pmRNSNotification of Major Holdings
31st Jan 20207:00 amRNSAppointment of Non-Executive Director
23rd Jan 202010:20 amRNSNotification of Major Holdings
17th Jan 202012:33 pmRNSNotification of Major Holdings
15th Jan 20204:18 pmRNSPDMR Dealing
14th Jan 20207:00 amRNSPre-Close Trading Update
22nd Nov 20197:00 amRNSTrading Update
5th Nov 20197:00 amRNSAppointment of Group Supply Chain Director
29th Oct 20197:00 amRNSAppointment of Group E-Commerce Director
1st Oct 20197:00 amRNSDirectorate Change
27th Sep 20193:58 pmRNSNotification of Major Holdings
24th Sep 20193:32 pmRNSPDMR Dealings - Exercise of Option Shares
18th Sep 20197:00 amRNSInterim Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.